接受直接口服抗凝剂治疗的患者中抗凝效果随体重的变化情况。 - Suppr | 超能文献

Variability of the anticoagulant effect according to body weight in patients treated with direct oral anticoagulants.

作者信息

Belli Lorenzo, Radico Francesco, Auciello Raffaella, Patti Giuseppe, Gallina Sabina, Renda Giulia

机构信息

Department of Cardiology, Renzetti Hospital, Lanciano, Italy.

Department of Clinical Pathology, Renzetti Hospital, Lanciano, Italy.

出版信息

Intern Emerg Med. 2024 Jun;19(4):1167-1171. doi: 10.1007/s11739-024-03553-3. Epub 2024 Feb 9.

DOI:10.1007/s11739-024-03553-3

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Variability of the anticoagulant effect according to body weight in patients treated with direct oral anticoagulants.接受直接口服抗凝剂治疗的患者中抗凝效果随体重的变化情况。

Intern Emerg Med. 2024 Jun;19(4):1167-1171. doi: 10.1007/s11739-024-03553-3. Epub 2024 Feb 9.

2

A single center retrospective cohort study comparing low-molecular-weight heparins to direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer - A real world experience.一项单中心回顾性队列研究：比较低分子肝素与直接口服抗凝剂治疗癌症患者静脉血栓栓塞症——真实世界经验

J Oncol Pharm Pract. 2019 Jun;25(4):793-800. doi: 10.1177/1078155218757856. Epub 2018 Feb 20.

3

Direct Oral Anticoagulants in the Real World: Insights Into Appropriate Prescribing and Medication Use.现实世界中的直接口服抗凝剂：关于合理处方和药物使用的见解。

Can J Nurs Res. 2017 Sep;49(3):105-107. doi: 10.1177/0844562117716852. Epub 2017 Jul 5.

4

Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study.静脉血栓栓塞症抗凝延长治疗患者换用直接口服抗凝剂后对患者满意度的影响：SWAN 研究。

PLoS One. 2020 Jun 4;15(6):e0234048. doi: 10.1371/journal.pone.0234048. eCollection 2020.

5

Safety and efficacy of direct oral anticoagulants for venous thromboembolism and stroke prophylaxis in patients with hematologic malignancies.直接口服抗凝剂用于血液系统恶性肿瘤患者预防静脉血栓栓塞和中风的安全性及有效性

J Oncol Pharm Pract. 2020 Mar;26(2):351-360. doi: 10.1177/1078155219848810. Epub 2019 May 29.

6

Oral anticoagulant treatment in geriatric patients with nonvalvular atrial fibrillation in the era of direct oral anticoagulant agents.

Eur J Intern Med. 2014 Jun;25(5):e63-5. doi: 10.1016/j.ejim.2014.02.003. Epub 2014 Feb 23.

7

Direct oral anticoagulants in patients with nonvalvular atrial fibrillation and extreme body weight.非瓣膜性心房颤动及体重极端患者使用直接口服抗凝剂的情况

Eur J Clin Invest. 2022 Jan;52(1):e13658. doi: 10.1111/eci.13658. Epub 2021 Aug 10.

8

Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight.非瓣膜性心房颤动且低体重患者的直接口服抗凝剂。

J Am Coll Cardiol. 2019 Mar 5;73(8):919-931. doi: 10.1016/j.jacc.2018.11.051.

9

Peri-Procedural Management of Oral Anticoagulants in the DOAC Era.DOAC 时代口服抗凝药物的围手术期管理。

Prog Cardiovasc Dis. 2018 Mar-Apr;60(6):600-606. doi: 10.1016/j.pcad.2018.03.002. Epub 2018 Mar 10.

10

Geriatric Elements and Oral Anticoagulant Prescribing in Older Atrial Fibrillation Patients: SAGE-AF.老年因素与老年心房颤动患者口服抗凝药物的应用：SAGE-AF。

J Am Geriatr Soc. 2020 Jan;68(1):147-154. doi: 10.1111/jgs.16178. Epub 2019 Oct 1.

引用本文的文献

1

Current Antithrombotic Treatments for Cardiovascular Diseases: A Comprehensive Review.心血管疾病的当前抗血栓治疗：全面综述

Rev Cardiovasc Med. 2024 Aug 8;25(8):281. doi: 10.31083/j.rcm2508281. eCollection 2024 Aug.